For the Quarter Ending March 2026
Luliconazole Prices in North America
- In United States, the Luliconazole Price Index rose quarter-over-quarter in Q1 2026, driven by elevated production costs.
- The Luliconazole Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0%.
- The Luliconazole Price Index climbed in March 2026, supported by a 3.3% increase in consumer inflation.
- The Luliconazole Demand Outlook strengthened in March 2026 because retail sales grew 4.0% across domestic pharmacies.
- Luliconazole demand remained robust in March 2026 as the 4.3% unemployment rate sustained health insurance access.
- Industrial production grew 0.7% in March 2026, ensuring stable domestic chemical manufacturing capacity for Luliconazole synthesis.
- The Manufacturing Index expanded in March 2026, which solidified the upward Luliconazole Price Forecast for the quarter.
Why did the price of Luliconazole change in March 2026 in North America?
- Naphtha feedstock costs strengthened in the United States through March 2026, elevating baseline synthesis expenses.
- United States refining capacity contracted in Q1 2026, which tightened the availability of petrochemical feedstocks.
- Strong demand for synthetic active pharmaceutical ingredients emerged across the United States in January 2026.
Luliconazole Prices in APAC
- In China, the Luliconazole Price Index rose quarter-over-quarter in Q1 2026, driven by rising factory-gate prices.
- The Luliconazole Production Cost Trend increased in March 2026 as the PPI grew by 0.5%.
- The Luliconazole Demand Outlook remained steady in March 2026, supported by a 1.0% CPI increase.
- Industrial production grew 5.7% in March 2026, ensuring ample raw material supply for Luliconazole synthesis.
- Retail sales grew 1.7% in March 2026, softening downstream retail demand for Luliconazole antifungal treatments.
- The Manufacturing Index expanded in March 2026, reflecting robust operational capacity for Luliconazole API formulation.
- The Luliconazole Price Forecast indicated upward pressure in Q1 2026 as Asian spot LNG prices surged.
Why did the price of Luliconazole change in March 2026 in APAC?
- Asian spot LNG prices surged in Q1 2026, elevating energy-intensive Luliconazole production costs very significantly.
- Demand for carbon disulfide, a key Luliconazole feedstock, intensified in January 2026 across the region.
- Piped natural gas deliveries from Russia to China surged in Q1 2026, altering supply dynamics.
Luliconazole Prices in Europe
- In Germany, the Luliconazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging natural gas feedstock costs.
- The Luliconazole Production Cost Trend increased in March 2026 as consumer inflation reached 2.7 percent year-over-year.
- Despite a -0.2 percent year-over-year producer price decline in March 2026, natural gas feedstock prices surged rapidly.
- The Manufacturing Index expanded in March 2026, while industrial production remained flat at 0.0 percent in February 2026.
- The Luliconazole Demand Outlook weakened in March 2026, aligning with a -2.0 percent year-over-year retail sales decline.
- Flexible liquefied natural gas cargoes diverted from Europe to Asian markets during the quarter ending March 2026.
- The Luliconazole Price Forecast indicated an upward trend in March 2026 following significant global gas supply tightening.
Why did the price of Luliconazole change in March 2026 in Europe?
- European natural gas exchange prices surged rapidly in March 2026, elevating upstream chemical manufacturing costs.
- Global liquefied natural gas supply tightened significantly in March 2026 due to Middle East disruptions.
- German industrial producer prices for energy increased sharply in March 2026, driving up synthesis expenses.
For the Quarter Ending December 2025
Luliconazole Prices in North America
- In United States, Luliconazole Price Index fell in Q4 2025, driven by soft overall chemical demand throughout 2025.
- Luliconazole production costs increased, influenced by a 2.7% year-over-year CPI rise in December 2025 for raw materials.
- Demand for Luliconazole supported by 3.3% year-over-year retail sales increase in November 2025.
- Luliconazole Price Index faced downward pressure from significant US chemical industry overcapacity throughout 2025.
- Input cost inflation for the broader manufacturing sector eased in December 2025, moderating production expenses.
- A 3.0% year-over-year PPI increase in November 2025 indicated rising input costs for intermediates.
- US manufacturing new orders declined in December 2025, contributing to a soft demand outlook for Luliconazole.
- A 4.4% unemployment rate in December 2025 supported consumer spending on health products, including Luliconazole.
- Industrial production expanded by 2.0% year-over-year in December 2025, supporting the broader chemical supply chain.
Why did the price of Luliconazole change in December 2025 in North America?
- Softening Luliconazole demand observed due to declining US manufacturing new orders in December 2025.
- Rising input costs for producers indicated by 3.0% year-over-year PPI increase in November 2025.
- Significant overcapacity within US chemical industry throughout 2025 exerted downward pressure.
Luliconazole Prices in APAC
- In China, the Luliconazole Price Index remained stable in Q4 2025, influenced by mixed macroeconomic signals.
- Luliconazole production costs declined in December 2025, as the Producer Price Index fell by 1.9% year-over-year.
- Demand for Luliconazole was supported by China's pharmaceutical market growth in 2025, driven by post-pandemic recovery.
- Luliconazole's price forecast suggests stability, despite low consumer spending with 0.9% retail sales growth in December 2025.
- Industrial Production increased by 5.2% year-over-year in December 2025, supporting a robust supply chain.
- The Manufacturing Index expanded in December 2025, indicating economic growth beneficial for Luliconazole's market.
- Luliconazole demand was tempered by a low Consumer Price Index of 0.8% year-over-year in December 2025.
- China's pharmaceutical and healthcare product exports strengthened in 2025, influencing Luliconazole trade flows.
Why did the price of Luliconazole change in December 2025 in APAC?
- Producer Price Index declined by 1.9% year-over-year in December 2025, reducing Luliconazole production costs.
- Retail sales growth was low at 0.9% year-over-year in December 2025, indicating subdued consumer demand.
- Industrial Production increased by 5.2% year-over-year in December 2025, supporting stable supply chain operations.
Luliconazole Prices in Europe
- In Germany, the Luliconazole Price Index fell quarter-over-quarter in Q4 2025, driven by increased competitive pressure in October 2025.
- Luliconazole production costs rose throughout Q4 2025 due to elevated raw material and high energy costs.
- Demand for Luliconazole faced headwinds as German chemical industry sentiment deteriorated sharply in October 2025.
- The Luliconazole demand outlook remained challenged by a contracting Manufacturing Index in December 2025.
- Retail sales rose 1.1% year-on-year in November 2025, but consumer confidence was pessimistic at -17.5 in December 2025.
- Luliconazole supply was impacted as capacity utilization in Germany's chemical industry fell to 71% in October 2025.
- Export sales for German manufacturing fell for a fifth consecutive month in December 2025, accelerating decline.
- A -2.5% PPI year-on-year decrease in December 2025 contributed to broader deflationary pressures.
- A 6.2% unemployment rate and 1.8% CPI year-on-year increase in December 2025 dampened consumer purchasing power.
Why did the price of Luliconazole change in December 2025 in Europe?
- Increased competitive pressure compelled German chemical companies to lower prices in October 2025.
- Input costs for German manufacturing rose in December 2025, alongside elevated raw material costs in Q4 2025.
- New orders in German manufacturing experienced a sustained decline in demand in December 2025.
For the Quarter Ending September 2025
Luliconazole Prices in North America
- In United States, the Luliconazole Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs and robust demand.
- Production costs for Luliconazole increased in Q3 2025, influenced by a 2.6% year-over-year PPI rise in August 2025.
- Input and energy costs for chemical manufacturing climbed in Q3 2025, with natural gas prices rising August to September.
- US antifungal drugs market demand strengthened in Q3 2025, supported by a 5.42% year-over-year retail sales increase in September 2025.
- Consumer confidence declined to 94.2 in September 2025, yet a 4.3% unemployment rate supported purchasing power.
- Chemical manufacturers' inventories tightened in Q3 2025 due to accelerated destocking, affecting Luliconazole supply.
- Industrial production growth was sluggish at 0.1% year-over-year in September 2025, indicating slower overall manufacturing activity.
- The Luliconazole Price Index is forecast to maintain an upward trend, given persistent cost pressures and steady demand drivers.
Why did the price of Luliconazole change in September 2025 in North America?
- Rising input costs, with a 2.6% PPI increase in August 2025, elevated Luliconazole production expenses.
- Strong consumer demand, supported by a 5.42% retail sales increase in September 2025, boosted market pull.
- Tightening chemical manufacturer inventories in Q3 2025 contributed to supply constraints for Luliconazole.
Luliconazole Prices in Europe
- In Germany, the Luliconazole Price Index fell quarter-over-quarter in Q3 2025, driven by declining producer prices and feedstock costs.
- Luliconazole production costs decreased in Q3 2025, as producer prices for basic chemicals declined by 1.7% in September 2025.
- Demand for Luliconazole strengthened in Q3 2025, supported by firming pharmaceutical output and 0.8% retail sales growth.
- The Luliconazole Price Forecast faces pressure from contracting industrial production, down 1.0% year-on-year in September 2025.
- High operating costs, from 2.4% CPI year-on-year in September 2025, partially offset lower petrochemical feedstock benefits.
- Chemical industry inventories shrank in Q3 2025 due to accelerating destocking efforts, impacting supply.
- Increased imports of pharmaceutical products into Germany in Q3 2025 intensified domestic market competition.
- A contracting Manufacturing Index in September 2025 reflected a broader economic slowdown.
- Low 3.9% unemployment in September 2025 supported consumer purchasing, despite low consumer confidence (-23.6 index).
Why did the price of Luliconazole change in September 2025 in Europe?
- Producer prices for basic chemicals declined 1.7%, reducing Luliconazole manufacturing input costs.
- Increased pharmaceutical imports intensified domestic market competition.
- High operating costs, from 2.4% CPI, pressured chemical industry profitability.
Luliconazole Prices in APAC
- In China, the Luliconazole Price Index fell quarter-over-quarter in Q3 2025, influenced by deflationary CPI (-0.3%) in September.
- Luliconazole production costs declined during Q3 2025, driven by a -2.3% PPI in September 2025 and falling coal prices.
- Demand for Luliconazole was supported by a thriving pharmaceutical market and rising healthcare spending in Q3 2025.
- Consumer confidence at 89.6 in September 2025 indicated pessimism, tempering Luliconazole demand in the OTC segment.
- China's industrial production increased by 6.5% year-on-year in September 2025, signaling robust economic activity.
- Retail sales grew by 3.0% year-on-year in September 2025, indicating stable consumer demand for healthcare products.
- Trade flows for APIs faced disruptions in Q3 2025 due to port congestion and ongoing U.S.-China trade tensions.
- The Manufacturing Index contracted in September 2025, reflecting a general slowdown in the broader industrial sector.
Why did the price of Luliconazole change in September 2025 in APAC?
- Deflationary CPI (-0.3%) in September 2025 exerted downward pressure on Luliconazole market prices.
- Luliconazole production costs decreased due to -2.3% PPI and falling coal prices in Q3 2025.
- Mixed demand signals, with stable retail sales (3.0%) but contracting consumer confidence (89.6) in September.
